SMS-based Mobile Health Intervention for Nutritional Status and Treatment Outcome Among TB Patients

NCT ID: NCT04242472

Last Updated: 2020-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

440 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-31

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ethiopia is one of the high burden Tuberculosis countries and Tuberculosis is still the leading cause of mortality due to communicable diseases in the country. Nutritional status is one of the predictors of TB treatment outcomes. Thus, the current practices need integration of nutritional intervention in the DOT using Mobile health intervention. However, to investigator's knowledge, there is no sufficient evidence on the effect SMS text Messaging Mobile Health intervention on nutritional status and TB treatment outcomes in Ethiopia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To ensure the quality of SMS intervention, nutritional related SMS text message will be developed systematically through reviewing literature, systematic reviews and guidelines and appropriate behavioral theories by involving experts and patients. Automated SMS will be sent from one computer database at the scheduled date and time. A validated questionnaire will be adapted and pre-tested to check for any error. Adequate sample size is calculated for both arms with the ratio of 1:1 allocation. Standardized Anthropometric measurement, FANTA Household Dietary Diversity Score and WHO TB treatment outcome classification will be used for assessing the outcome variables. The data collectors will be trained on the objective, screening of eligible participants, the procedure of data collection, and how to assure the quality and security of the data based on the protocol. Continuous supervision will be employed throughout the data collection and intervention period. The data will be collected electronically and will be exported to STATA for analysis. Intention to treat analysis and regression analysis model will be employed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis Undernutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A Cluster Randomized Trial (CRT) with parallel design will be employed.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
Participants and providers will not be blind to the study intervention. Nutrition and tuberculosis treatment outcomes will be assessed by two independent reviewers without knowledge of each participant's treatment allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SMS group

Nutrition-related SMS messages in addition to standard of care TB treatment with directly observed therapy

Group Type EXPERIMENTAL

SMS-based Mobile Health intervention

Intervention Type BEHAVIORAL

Nutritional related SMS text message mobile health intervention will be provided to Tuberculosis patients.

Control group

Standard care of TB treatment with directly observed therapy alone

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS-based Mobile Health intervention

Nutritional related SMS text message mobile health intervention will be provided to Tuberculosis patients.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who is following their anti TB treatment for at most two weeks and below
* Patient who have their own mobile phone
* Patient who is able to read and understand national official language (Amharic)

Exclusion Criteria

* Patient whose TB treatment regimen more than 6 months
* Patient who is pregnant and lactating mothers
* Patient who enrolled other Interventional research
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fogarty International Center of the National Institute of Health

NIH

Sponsor Role collaborator

Addis Ababa University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zekariyas Sahile

PhD candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Damen Haile Mariam

Role: STUDY_CHAIR

Addis Ababa University School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Addis Ababa Health Bureau

Addis Ababa, , Ethiopia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ethiopia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zekariyas Sa Nezenega

Role: CONTACT

911072963 ext. +251

Damen Haile Mariam

Role: CONTACT

929438641 ext. +251

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yohannes Dr

Role: primary

911384599 ext. +251

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D43TW009127

Identifier Type: NIH

Identifier Source: secondary_id

View Link

TB-MeNu

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Digital Health Intervention to Improve TPT Uptake
NCT07313995 NOT_YET_RECRUITING NA
DeMONSTRATE-TB Study in Ethiopia
NCT06719193 RECRUITING PHASE2/PHASE3